United States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation. (2022). Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS buprenorphine practice guidelines. U.S. Department of Health and Human Services.
Chicago Style (17th ed.) CitationUnited States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation. Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines. [Washington, D.C.]: U.S. Department of Health and Human Services, 2022.
MLA (9th ed.) CitationUnited States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation. Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines. U.S. Department of Health and Human Services, 2022.